KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Gains from Investment Securities (2016 - 2026)

Insulet filings provide 16 years of Gains from Investment Securities readings, the most recent being $25.9 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 254.79% to $25.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.9 million, a 240.79% increase, with the full-year FY2025 number at $25.9 million, up 240.79% from a year prior.
  • Gains from Investment Securities hit $25.9 million in Q4 2025 for Insulet, up from $7.3 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $27.7 million in Q4 2021 to a low of -$26.8 million in Q3 2021.
  • Median Gains from Investment Securities over the past 5 years was $4.7 million (2022), compared with a mean of $5.1 million.
  • Biggest five-year swings in Gains from Investment Securities: crashed 26900.0% in 2021 and later surged 254.79% in 2025.
  • Insulet's Gains from Investment Securities stood at $27.7 million in 2021, then plummeted by 105.05% to -$1.4 million in 2022, then crashed by 835.71% to -$13.1 million in 2023, then surged by 155.73% to $7.3 million in 2024, then surged by 254.79% to $25.9 million in 2025.
  • The last three reported values for Gains from Investment Securities were $25.9 million (Q4 2025), $7.3 million (Q4 2024), and -$5.6 million (Q3 2024) per Business Quant data.